Theriva Biologics SG&A Expense (Quarterly) Trends

Theriva Biologics Inc (TOVX)

0.4195 +0.01 (+2.33%) USD | NYAM | Apr 26, 16:00

0.4199 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1993. Upgrade now.

Date	Value
December 31, 2023	2.021M
September 30, 2023	0.212M
June 30, 2023	2.687M
March 31, 2023	2.201M
December 31, 2022	4.246M
September 30, 2022	2.416M
June 30, 2022	1.541M
March 31, 2022	1.655M
December 31, 2021	2.486M
September 30, 2021	1.303M
June 30, 2021	1.265M
March 31, 2021	1.419M
December 31, 2020	1.153M
September 30, 2020	1.197M
June 30, 2020	1.286M
March 31, 2020	1.393M
December 31, 2019	1.283M
September 30, 2019	1.098M
June 30, 2019	1.044M
March 31, 2019	1.154M
December 31, 2018	1.202M
September 30, 2018	1.474M
June 30, 2018	1.431M
March 31, 2018	1.62M
December 31, 2017	2.027M

Date	Value
September 30, 2017	1.705M
June 30, 2017	1.644M
March 31, 2017	2.09M
December 31, 2016	3.475M
September 30, 2016	2.095M
June 30, 2016	2.147M
March 31, 2016	2.426M
December 31, 2015	2.535M
September 30, 2015	1.604M
June 30, 2015	2.222M
March 31, 2015	1.713M
December 31, 2014	1.859M
September 30, 2014	1.218M
June 30, 2014	1.814M
March 31, 2014	1.122M
December 31, 2013	1.562M
September 30, 2013	1.89M
June 30, 2013	1.258M
March 31, 2013	1.122M
December 31, 2012	1.295M
September 30, 2012	1.073M
June 30, 2012	1.176M
March 31, 2012	1.468M
December 31, 2011	0.249M
September 30, 2011	0.582M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.212M

Minimum

Sep 2023

4.246M

Maximum

Dec 2022

1.679M

Average

1.393M

Median

Mar 2020

SG&A Expense (Quarterly) Benchmarks